Development of point-of-care (POC) molecular diagnostic devices is critical for the global healthcare and personalized medicine. Current POC molecular diagnostic platforms are based on polymeric or glass substrates. If we use them frequently for molecular diagnostics in both developed and developing countries, the swamping of disposable medical waste is serious problem. In order to solve this problem, we are developing integrative paper-based molecular diagnostic devices (IPMD) with the capability of nucleic acid detection of HIV from blood, which allow safe and proper disposal for public health.
Project end date: 09/09/13